SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-18-004383
Filing Date
2018-04-18
Accepted
2018-04-18 10:43:20
Documents
6
Period of Report
2018-04-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fcsc41818form8-k.htm 8-K 24612
2 EXHIBIT 99.1 a041718finalfcscreleasev.htm EX-99.1 11450
3 a041718finalfcscreleasev001.jpg GRAPHIC 222351
4 a041718finalfcscreleasev002.jpg GRAPHIC 220299
5 a041718finalfcscreleasev003.jpg GRAPHIC 242809
6 image0a10.jpg GRAPHIC 74382
  Complete submission text file 0001628280-18-004383.txt   1082014
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31564 | Film No.: 18760453
SIC: 2834 Pharmaceutical Preparations